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C

oronavirus Disease 2019 (COVID-19), emerged
in Wuhan, China, in December 2019. As of 10
March 2020, COVID-19 cases have been reported in 114 countries from all Continents except Antarctica, with accumulative 80 932 cases in China and 29 432
in other countries [1]. The transmission potential of
COVID-19, determined by reproduction number (R0) of 3.28, is much higher that of severe acute respiratory syndrome (SARS) [2]. Bold measures taken by China have effectively curbed the rapid spread of
this new respiratory disease source and changed the dangerous process of rapid spread of the epidemic
[3]. The world is not yet ready to organize and implement the measures that have been proved to be efficient and effective by China to block or minimize the spread of new coronavirus [3]. The crude case-fatality rate (CFR) of COVID-19 is reported to be 2.3% in all patients [4], while higher to be 61.5% in critically ill patients [5]. Therefore, early screening and quarantining mild or asymptomatic cases and early
diagnosis of sever patients for intensive treatment are urgent to avoid the pandemic of COVID-19.

Neither chest CT nor RT-PCR testing alone is accurate enough for the diagnosis of COVID-19 infection.

Reverse Transcription-Polymerase Chain Reaction (RT-PCR) testing was recommended to confirm COVID-19 cases by China medical authority [6], however the total positive rate of RT-PCR for throat swab
samples was about 30% to 60% at initial presentation. Chest Computed Tomography (CT), a routine imaging method, has also been applied to diagnose COVID-19 infection [7]. A study on the correlation of
chest CT and RT-PCR testing of COVID-19 based on 1014 cases demonstrated that the sensitivity of chest
CT imaging for COVID-19 was 97%
(580/601), and the specificity was 25%
Parallel tests with CT and RT-PCT are recom(105/413), with RT-PCR as a diagnosis crimended to be applied in the screening of COterion [8]. As a new emerging infectious disVID-19 for isolation, while series test with CT
ease, there is no gold criteria for the diagnosis of COVID-19. Our current study showed
or RT-PCT should be used in COVID-19 diagthat if chest CT was taken as a reference of
nosis confirmation for treatment.
diagnosis standard, the sensitivity of RT-PCR
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Table 1. The performance of RT-PCR for COVID-19 infection
with chest CT result as reference
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CT

RT-PCR
Sensitivity
Specificity
(95 % CI)
(95% CI)
positive negative
Positive
580
308
83%
65%
(62%-68%) (76%-89%)
Negative
21
105
CT – computed tomography, RT-PCR – reverse transcriptase
polymerase chain reaction, CI – confidence interval

testing for COVID-19 was 65% (580/888), and the specificity
is 83% (105/126) (Table 1). Thus, if both sensitivity and specificity were taken into account simultaneously, neither chest
CT nor RT-PCR testing alone is accurate enough for the diagnosis of COVID-19 infection.

Considering that asymptomatic cases are also of higher transmission potential, sensitivity should be first considered for the
screening purpose of COVID-19 infection. When confirmation for intensive treatment, specificity should be first considered to avoid false treatment. Parallel tests and serial test are needed to increase both sensitivity and specificity. Parallel tests perform RT-PCR and CT imaging at the same time and the results are cross-referenced
to make the diagnosis [9]. Serial test employs as a secondary screening test which is performed only if the
result of initial screening test is positive [9]. For screening purposes, parallel tests, ie, positive in either
RT-PCR or chest CT is used to clinically diagnose COVID-19, can improve sensitivity and decrease false
negative cases. For therapy purposes serial tests should be used to improve specificity and decrease false
positive cases. Consequently, we recommend that parallel tests are used in screening, while series tests
should be used for diagnosis confirmation of COVID-19. The proposed strategic approach for screening
and diagnosis confirmation of COVID-19 infection might also be of reference significance for other countries or other emerging infectious disease.

Photo: Parallel or serial test (from the authors’ own collection, used with permission).
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